Clinical Trial Update: A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma [Phase 3]

View source ↗

Summary

Phase III trial comparing Paclitaxel plus 5-fluorouracil to cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (esopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED